Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$2.89B |
| 2 |
Tesla
TSLA
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$1.77B |
| 4 |
VICI Properties
VICI
|
+$1.23B |
| 5 |
Amazon
AMZN
|
+$1.22B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$3.57B |
| 2 |
CERN
Cerner Corp
CERN
|
+$3.01B |
| 3 |
Occidental Petroleum
OXY
|
+$1.31B |
| 4 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$1.05B |
| 5 |
PBCT
People's United Financial Inc
PBCT
|
+$961M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.63% |
| 2 | Healthcare | 14.28% |
| 3 | Financials | 13.35% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Industrials | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INFI
3576
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $3.33M | ﹤0.01% |
5,270,916
-514,372
| -9% | -$395K |
|
|
APRN
3577
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
| $3.32M | ﹤0.01% |
75,991
+3,607
| +5% | +$147K |
|
3578
Innovative Solutions & Support
ISSC
$361M
| $3.3M | ﹤0.01% |
458,936
+6,222
| +1% | +$49.6K |
|
|
LSEA
3579
DELISTED
Landsea Homes
LSEA
| $3.3M | ﹤0.01% |
496,008
-13,212
| -3% | -$103K |
|
3580
Altisource Portfolio Solutions
ASPS
$65.8M
| $3.3M | ﹤0.01% |
38,420
| – | – |
|
|
SNCR
3581
DELISTED
Synchronoss Technologies
SNCR
| $3.29M | ﹤0.01% |
318,017
+14,004
| +5% | +$177K |
|
3582
Cineverse
CNVS
$65.6M
| $3.28M | ﹤0.01% |
333,259
| – | – |
|
3583
Northern Technologies International Corp
NTIC
$80M
| $3.28M | ﹤0.01% |
350,562
| – | – |
|
3584
Vor Biopharma
VOR
$1.28B
| $3.27M | ﹤0.01% |
32,857
-165
| -0.5% | -$16.9K |
|
3585
BioAtla
BCAB
$5.74M
| $3.26M | ﹤0.01% |
22,893
-8,233
| -26% | -$1.31M |
|
|
DMK
3586
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $3.25M | ﹤0.01% |
92,581
| – | – |
|
|
BORR
3587
Borr Drilling
BORR
$1.19B
| $3.24M | ﹤0.01% |
+703,344
| New | +$3.49M |
|
3588
PAVmed
PAVM
$33.9M
| $3.24M | ﹤0.01% |
7,699
-1,672
| -18% | -$808K |
|
|
ACCS
3589
ACCESS Newswire
ACCS
$26.3M
| $3.24M | ﹤0.01% |
127,141
-40,530
| -24% | -$1M |
|
3590
NLI Holdings
NL
$317M
| $3.24M | ﹤0.01% |
327,835
+30,637
| +10% | +$246K |
|
|
BBQ
3591
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
| $3.23M | ﹤0.01% |
310,331
| – | – |
|
|
ATYR
3592
aTyr Pharma
ATYR
$50.1M
| $3.23M | ﹤0.01% |
1,139,533
| – | – |
|
3593
Jakks Pacific
JAKK
$293M
| $3.21M | ﹤0.01% |
253,924
| – | – |
|
3594
Zymeworks
ZYME
$1.67B
| $3.21M | ﹤0.01% |
606,690
+193,412
| +47% | +$1.17M |
|
3595
Graham Corp
GHM
$1.31B
| $3.21M | ﹤0.01% |
464,021
| – | – |
|
3596
inTEST
INTT
$177M
| $3.21M | ﹤0.01% |
470,599
| – | – |
|
3597
American Resources Corp
AREC
$293M
| $3.19M | ﹤0.01% |
2,200,927
| – | – |
|
3598
ReposiTrak
TRAK
$159M
| $3.19M | ﹤0.01% |
724,207
-5,472
| -0.7% | -$27.1K |
|
|
CLSD
3599
DELISTED
Clearside Biomedical
CLSD
| $3.18M | ﹤0.01% |
144,378
| – | – |
|
|
ETNB
3600
DELISTED
89bio
ETNB
| $3.18M | ﹤0.01% |
988,352
+582,933
| +144% | +$1.76M |
|
Similar funds
Vanguard Group's Q2 2022 Portfolio in Review
As of Q2 2022, Vanguard Group held 4,705 positions worth $3.56T, down 16% from $4.23T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q2 2022: portfolio turnover was 3.5%. Vanguard Group opened 80 new positions and exited 84, leaving the 4,705-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Vanguard Group's largest Q2 2022 buy was ESAB: 5,042,669 shares worth $221M.
- Vanguard Group added most to Warner Bros in Q2 2022, an estimated $2.89B increase.
- Vanguard Group's biggest Q2 2022 reduction was AT&T, cutting an estimated $3.57B.
- Vanguard Group fully exited Cerner Corp in Q2 2022, selling an estimated $3.01B.
- Vanguard Group's ten largest holdings make up 20% of its $3.56T portfolio in Q2 2022.
- Vanguard Group opened 80 new positions and closed 84 in Q2 2022.
- Vanguard Group's portfolio value fell 16% quarter-over-quarter to $3.56T.
Based on Vanguard Group's 13F filing for Q2 2022, filed 12 Aug 2022.